Pre-diabetic biomarker ID'd at Virginia Tech; Karolinska researchers highlight immuno-oncology targets

> Virginia Tech researchers say they identified a biomarker in pre-diabetic individuals that could help prevent them from developing Type II diabetes. Release

> A study by researchers at Sweden's Karolinska Institutet says that cells in tumor blood vessels protect cancer cells from tumor-killing immune cells. Release

> Scientists at the University of Bonn showed how the body provides killer cells with a helper in the case of an infection. Release

> An international group of researchers led by Carnegie Mellon University physicists Mathias Lösche and Frank Heinrich have established the structure of an important tumor suppressing protein, PTEN. Release

Suggested Articles

A newfound link between BMAL1, a protein involved in circadian rhythms, and triple-negative breast cancer could point to new treatment strategies.

Combining a DYRK1A inhibitor with popular GLP-1 receptor agonists regenerates insulin-producing beta cells, Mount Sinai scientists found.

Arming a peptide taken from the virus that causes foot-and-mouth disease in cows with the payload tesirine shows promise against pancreatic cancer.